Models of myocardial ischemia

Drug Discovery Today: Disease Models

Volumn 3, Issue 3, 2006, Pages 263-271

  Ytrehus, Kirsti ^a  

^a Faculty of Medicine   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE RECEPTOR STIMULATING AGENT; BASIC FIBROBLAST GROWTH FACTOR; CYCLOOXYGENASE 2 INHIBITOR; CYTOCHROME P450 INHIBITOR; GLUCOSE; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; POTASSIUM; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL CULTURE; CELL DEATH; CELL SURVIVAL; COMPUTER MODEL; CORONARY ARTERY BLOOD FLOW; DISEASE COURSE; DISEASE MODEL; DOPPLER ECHOGRAPHY; ECHOCARDIOGRAPHY; ENDOTHELIUM CELL; EX VIVO STUDY; EXPERIMENTAL ANIMAL; FUNCTIONAL GENOMICS; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HIBERNATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIC PRECONDITIONING; ISOLATED HEART; MITOCHONDRION; MOLECULAR IMAGING; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXYGEN CONSUMPTION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; STUNNED HEART MUSCLE;

EID: 33751242013     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2006.10.013     Document Type: Review

References (40)

1. Nithipatikom K., et al. Effects of selective inhibition of cytochrome P-450 ω-hydroxylases and ischemic preconditioning in myocardial protection. Am. J. Physiol. 290 (2006) H500-H505
2. Granville D.J., et al. Reduction of ischemia and reperfusion-induced myocardial damage by cytochrome P450 inhibitors. PNAS 101 (2004) 1321-1326
3. Silva G.V., et al. Mesenchymal Stem Cells Differentiate into an Endothelial Phenotype, Enhance Vascular Density, and Improve Heart Function in a Canine Chronic Ischemia Model. Circulation 111 (2005) 150-156
4. Liu Y., et al. Effects of basic fibroblast growth factor microspheres on angiogenesis in ischemic myocardium and cardiac function: analysis with dobutamine cardiovascular magnetic, resonance tagging. Eur. J. Cardiotorac. Surg. 30 (2006) 103-108
5. Lyseggen E., et al. Myocardial train analysis in acute coronary occlusion. a tool to assess myocardial viability and reperfusion. Circulation 112 (2005) 3901-3910
6. Steensrud T., et al. Replacing potassium with nicorandil in cold St. Thomas' hospital cardioplegia improves preservation of energetics and function in pig hearts. Ann. Thorac. Surg. 77 (2004) 1391-1397
7. Tsang A., et al. Myocardial postconditioning: reperfusion injury revisited. Am. J. Physiol. 289 (2005) H2-H7
8. Zhao Z.Q., et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am. J. Physiol. 285 (2003) H579-H588
9. Schwartz L.M., et al. Ischemic postconditioning during reperfusion activates Akt and ERK without protecting against lethal myocardial ischemia-reperfusion injury in pigs. Am. J. Physiol. 290 (2006) H1011-H1018
10. 2b receptor cascade. Card. Res. 70 (2006) 308-314
11. Krenz M., et al. Acute ethanol exposure fails to elicit preconditioning-like protection in in situ rabbit hearts because of its continued presence during ischemia. J. Am. Coll. Cardiol. 37 (2001) 601-607
12. Ytrehus K., et al. Rat and rabbit heart infarction: effect of anesthesia, perfusate, risk zone, and methods of infarct sizing. Am. J. Physiol. 267 (1994) H2383-H2390
13. Tsuchida A., et al. The anti-infarct effect of an adenosine A1 selective agonist is diminished after prolonged infusion as is the cardioprotective effect of ischemic preconditioning in rabbit heart. J. Mol. Cell Cardiol. 26 (1994) 303-311
14. Qvigstad E., et al. Dual Serotonergic Regulation of Ventricular Contractile Force Through 5-HT2A and 5-HT 4 Receptors Induced in the Acute Failing Heart. Circ. Res. 97 (2005) 268-276
15. Tada H., et al. Endogenous erythropoietin system in non-hematopoietic lineage cells plays a protective role in myocardial ischemia/reperfusion. Card. Res. 71 (2006) 466-477
16. Nishihara M., et al. Erythropoietin affords additional cardioprotection to preconditioned hearts by enhanced phosphorylation of glycogen synthase kinase-3β. Am. J. Physiol. 291 (2006) H748-H755
17. Yang Z., et al. Cardiac overexpression of A1-adenosine receptor protects intact mice against myocardial infarction. Am. J. Physiol. 282 (2002) H949-H955
18. Shiomi T., et al. Overexpression of gluthatione peroxidise prevents left ventricular remodelling and failure after myocardial infarction in mice. Circulation 109 (2004) 544-549
19. Jayakumar J., et al. Heart shock protein 70 gene transfection protects mitochondrial and ventricular function against ischemia- reperfusion injury. Circulation 104 (2001) 303-307
20. Tanaka M., et al. Overexpression of human copper/zinc superoxide dismutase (SOD1) suppress ischemia-reperfusion injury and subsequent development of graft coronary artery disease in murine cardiac grafts. Circulation 110 (2004) 200-206
21. Sovershaev M.A., et al. Preconditioning by 17{beta}-estradiol in isolated rat heart depends on PI3-K/PKB pathwat, PKC and ROS. Am. J. Physiol. 291 (2006) H1554-H1562
22. Penna C., et al. Post-conditioning reduces infarct size in the isolated rat heart: Role of coronary flow and pressure and the nitric oxide/cGMP pathway. Basic Res. Cardiol. 101 (2006) 168-179
23. Sutherland F.J., et al. Mouse isolated perfused heart: Characteristics and cautions. Clin. Exp. Pharmacol. Physiol. 30 (2003) 867-878
24. Aasum E., et al. Age-Dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice. Diabetes 52 (2003) 434-441
25. Willems L., et al. Age-related changes in ischemic tolerance in male and female mouse hearts. J. Mol. Cell Cardiol. 38 (2004) 245-256
26. Shanmuganathan S., et al. Mitochondrial permeability transition pore as a target for cardioprotection in the human heart. Am. J. Physiol. 289 (2005) H237-H242
27. Juhaszova M., et al. Glycogen synthase kinase-3β mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J. Clin. Invest. 113 (2004) 1535-1549
28. Okada T., et al. Integrated pharmacological preconditioning and memory of cardioprotection: role of protein kinase C and phosphatidylinositol 3-kinase. Am. J. Physiol. 289 (2005) H761-H767
29. Claycomb W.C., et al. HL-1 cells: A cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc. Natl. Acad. Sci. U S A 95 (1998) 2979-2984
30. Gross E.R., et al. The JAK/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3β. Am. J. Physiol. 291 (2006) H827-H834
31. ATP channel-dependent delta opioid preconditioning. J. Surg. Res. 114 (2003) 187-194
32. Tantini B., et al. Involvement of polyamines in apoptosis of cardiac myoblasts in a model of simulated ischemia. J. Mol. Cell Cardiol. 40 (2006) 775-782
33. Tanno M., et al. Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia. Circ. Res. 93 (2003) 254-261
34. Nygren A., et al. Measurements of electrophysiological effects of components of acute ischemia in langendorff-perfused rat hearts using voltage-sensitive dye mapping. J. Cardiovasc. Electrophysiol. 17 (2006) S113-S123
35. Keener J.P. Model for the onset of fibrillation following coronary artery occlusion. J. Cardiovasc. Electrophysiol. 14 (2003) 1225-1232
36. Thiele I., et al. Candidate metabolic network states in human mitochondria. impact of diabetes, ischemia, and diet. J. Biol. Chem. 280 (2005) 11683-11695
37. Wang M., et al. Estrogen receptor-α mediates acute myocardial protection in females. Am. J. Physiol. 290 (2006) H2204-H2209
38. Bolli R., et al. Molecular and cellular mechanisms of myocardial stunning. Physiol. Rev. 79 (1999) 609-634
39. Downey J.M., et al. We think we see a pattern emerging here. Circ. 111 (2005) 120-121
40. Das D.K., et al. Mitochondrial function in cardiomyocytes: target for cardioprotection. Curr. Opin. Anaestesiol. 18 (2005) 77-82